患者様やご家族など一般の方向け臨床・治癒情報サイト　臨床研究情報ポータルサイト

• 進捗状況
• 試験名
• 対象疾患名
• 地域
• 登録日
•  

• Not recruiting

• Pharmacodynamics, Pharmacokinetics, and Safety of ASP1941 in Patients With Type 1 Diabetes Mellitus
• Type 1 Diabetes Mellitus
• Japan
• 2015-08-18

• Not recruiting

• Dose-ranging Study in Patients With Type 1 Diabetes Mellitus
• Type 1 Diabetes Mellitus;Type 1 Diabetes Mellitus;Type 1 Diabetes Mellitus;Type 1 Diabetes Mellitus
• United States
• 2015-05-29

• Not recruiting

• Efficacy and Safety of Sotagliflozin in Young Adult Patients With Type 1 Diabetes Mellitus and Elevated Hemoglobin A1C
• Type 1 Diabetes Mellitus;Type 1 Diabetes Mellitus;Type 1 Diabetes Mellitus;Type 1 Diabetes Mellitus
• United States
• 2015-02-19

• Not recruiting

• Metabolic Profiling of Type 1 Diabetes Mellitus in Children and Adolescents
• Type1diabetes;Type1diabetes;Type1diabetes;Type1diabetes
• Belgium
• 2016-12-12

• Not recruiting

• A Randomised Proof-of-Principle Trial Investigating Pharmacodynamics, Pharmacokinetics, and Safety of NNC0143-0406 in Subjects With Type 1 Diabetes Mellitus
• Diabetes;Diabetes Mellitus, Type 1
• Austria
• 2016-10-17

• Recruiting

• Safety Study and Therapeutic Effects of Umbilical Cord Blood Treg on Autoimmune Diabetes
• Diabetes Mellitus, Type 1;Diabetes Mellitus, Type 1;Diabetes Mellitus, Type 1;Diabetes Mellitus, Type 1
• China
• 2016-10-11

• Not recruiting

• A Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Anifrolumab in Adult Type I Interferon Test High Systemic Lupus Erythematosus Subject With Active Skin Manifestations
• Systemic Lupus Erythematosus
• Hungary, Korea, Republic of, Poland, United States
• 2016-09-23

• Recruiting

• Preservation C-peptide in type 1 diabetes mellitus
• Type 1 diabetes mellitus br>Nutritional, Metabolic, Endocrine Type 1 diabetes mellitus
• Croatia
• 2016-09-15

• Not recruiting

• Insulin Glulisine and Aspart in Postprandial Glycemic Control After High-GI Meal in Children With Type 1 Diabetes Mellitus
• Type 1 Diabetes Mellitus
• Poland
• 2012-08-28

• Not Recruiting

• Comparison of a new formulation of insulin glargine with Lantus in patients with type 1 diabetes mellitus
• Type 1 diabetes mellitus br>MedDRA version: 18.0 Level: PT Classification code 10067584 Term: Type 1 diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disorders ;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
• Canada, Czech Republic, Denmark, Estonia, Finland, Hungary, Japan, Latvia, Netherlands, Puerto Rico, Sweden, United States
• 2012-08-23

• Not recruiting

• Ovarian Ageing in Type 1 Diabetes Mellitus
• Type 1 Diabetes Mellitus
• Netherlands
• 2012-08-13

• Not recruiting

• The Effects of High and Low Blood Glucose Values on the Brain in Children With Type 1 Diabetes Mellitus
• Diabetes Mellitus
• United States
• 2012-08-06

• Not recruiting

• Type 1 Diabetes Mellitus Effect on Bone Mineral Density
• Diabetes Mellitus;Osteoporosis
• United States
• 2012-07-02

• Not recruiting

• Metformin in overweight adults with type 1 diabetes mellitus
• Type 1 diabetes mellitus;Overweight/obesity
• Australia
• 2012-06-20

• Not recruiting

• Lisofylline as Continuous Subcutaneous and Intravenous Administration in Subjects With Type 1 Diabetes Mellitus
• Type 1 Diabetes Mellitus;Type 1 Diabetes Mellitus;Type 1 Diabetes Mellitus;Type 1 Diabetes Mellitus
• United States
• 2012-05-18

• Not recruiting

• A Study to Compare LY2963016 to Lantus After a Single Dose to Participants With Type 1 Diabetes Mellitus
• Diabetes Mellitus, Type 1;Diabetes Mellitus, Type 1;Diabetes Mellitus, Type 1;Diabetes Mellitus, Type 1
• Germany
• 2012-05-15

• Not recruiting

• Skin Blood Flow in Patients With Type 1 Diabetes Mellitus Compared to Normal Controls
• Type 1 Diabetes,;Bone
• United States
• 2012-05-03

• Not Recruiting

• Preventing postoperative nausea and vomiting: Effect of Neurokinin-1 receptor antagonist(Fosaprepitant)
• postoperative nausea and vomiting
• Japan
• 2012-03-31

• Not recruiting

• Metabolic Effects of Honey in Type 1 Diabetes Mellitus
• Type 1 Diabetes Mellitus
• Egypt
• 2012-03-09

• Authorised

• Effect of Otelixizumab in New-Onset Type 1 Diabetes Mellitus (NOT1DM)
• NOT1DM is an autoimmune disease. This means that the immune system, the part of the body which usually helps to fight infections, mistakenly attacks cells that produce insulin in the body. Insulin is necessary for the uptake of sugar from the blood MedDRA version: 18.0 Level: LLT Classification code 10003814 Term: Autoimmune disease, not elsewhere classified System Organ Class: 100000004870 ;Therapeutic area: Body processes [G] - Immune system processes [G12]
• Belgium
• 2013-11-18